Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 18 citing articles:

Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 18
Broadly neutralizing antibodies against COVID-19
Daming Zhou, Jingshan Ren, Elizabeth E. Fry, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101332-101332
Open Access | Times Cited: 19
A lung-selective delivery of mRNA encoding broadly neutralizing antibody against SARS-CoV-2 infection
Wanbo Tai, Kai Yang, Yubin Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 18
Discovery and characterization of potent pan-variant SARS-CoV-2 neutralizing antibodies from individuals with Omicron breakthrough infection
Yu Guo, Guangshun Zhang, Qi Yang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 15
Breakthrough infection elicits hypermutated IGHV3-53/3-66 public antibodies with broad and potent neutralizing activity against SARS-CoV-2 variants including the emerging EG.5 lineages
Ling Li, Xixian Chen, Zuowei Wang, et al.
PLoS Pathogens (2023) Vol. 19, Iss. 12, pp. e1011856-e1011856
Open Access | Times Cited: 15
Comparative analysis of SARS‐CoV‐2 Omicron BA.2.12.1 and BA.5.2 variants
Chon Phin Ong, Zi‐Wei Ye, Kaiming Tang, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Closed Access | Times Cited: 23
Structural understanding of SARS-CoV-2 virus entry to host cells
Kim Le, Shrute Kannappan, Truc Kim, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 9
Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
Petros Eliadis, Annie Mais, Alexandros Papazisis, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 914-914
Open Access | Times Cited: 2
Potent antibodies against immune invasive SARS-CoV-2 Omicron subvariants
Lidong Wang, Yang Wang, Hao Zhou
International Journal of Biological Macromolecules (2023) Vol. 249, pp. 125997-125997
Closed Access | Times Cited: 6
Mechanism of a rabbit monoclonal antibody broadly neutralizing SARS-CoV-2 variants
Hangtian Guo, Yixuan Yang, Tiantian Zhao, et al.
Communications Biology (2023) Vol. 6, Iss. 1
Open Access | Times Cited: 5
Impact of Missense Mutations on Spike Protein Stability and Binding Affinity in the Omicron Variant
Vidhyanand Mahase, Adebiyi Sobitan, Qiaobin Yao, et al.
Viruses (2024) Vol. 16, Iss. 7, pp. 1150-1150
Open Access | Times Cited: 1
Mechanism of an RBM-targeted rabbit monoclonal antibody 9H1 neutralizing SARS-CoV-2
Xiaoyu Chu, Xinyu Ding, Yixuan Yang, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 660, pp. 43-49
Open Access | Times Cited: 3
Immunoinformatics and MD-simulation data suggest that Omicron spike epitopes are more interacting to IgG via better MHC recognition than Delta variant
Aniket Sarkar, Dipannita Santra, Anindya Sundar Panja, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110636-110636
Closed Access | Times Cited: 2
Broad‐Spectrum Engineered Multivalent Nanobodies Against SARS‐CoV‐1/2
Zhihong Wang, Zhuangzhuang Shi, Xiaochen Liao, et al.
Advanced Science (2024)
Open Access
Computational Analysis of Antibody Binding Mechanisms to the Omicron RBD of SARS-CoV-2 Spike Protein: Identification of Epitopes and Hotspots for Developing Effective Therapeutic Strategies
Mohammed Alshahrani
(2023)
Open Access | Times Cited: 1
Human monoclonal antibody F61 nasal spray effectively protected high-risk populations from SARS-CoV-2 variants during the COVID-19 pandemic from late 2022 to early 2023 in China
Ying Liu, Jiayou Zhang, Wen Liu, et al.
Emerging Microbes & Infections (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Preclinical evaluation of ISH0339, a tetravalent broadly neutralizing bispecific antibody against SARS-CoV-2 with long-term protection
Huabing Yang, Yuxin Chen, Dongcheng Jiang, et al.
Antibody Therapeutics (2023) Vol. 6, Iss. 2, pp. 97-107
Open Access
Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages
Harold Marcotte, Yunlong Cao, Fanglei Zuo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top